Cardiovascular-associated disease in an addicted population: an observation study. 2011

Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
Cardiology Department, ASL Torino, Italy. d.demarie@aslto2.it

BACKGROUND Illicit drugs such as cocaine, and methadone can induce acquired long QT syndrome. OBJECTIVE The aim of this study was to evaluate the prevalence of cardiovascular disease and to assess the risk of torsades de pointes in substance abuse patients either with methadone or buprenorphine maintenance therapy, or without any specific therapy for opiate addiction. METHODS From November 2008 to December 2009, 190 patients (153 men, mean age 38.2 years, 22-56 years) with a substance use disorder according to DSM IV TR criteria were included in the study. All patients underwent blood tests, serial electrocardiogram (ECG) and, when necessary, additional testing, including echocardiogram, exercise test and Holter monitoring. Age and sex-matched healthy controls were also evaluated and compared with the cases. RESULTS One hundred and twenty-five patients (65.7%) had associated diseases. The prevalence of coronary artery disease and hypertension was, respectively, 2.1 and 5.2% in the addicted population. The percentage of abnormal ECGs was 34.2% in the addicted population and 4.7% in the nonaddicted population (P < 0.001). Twenty-five addicted patients had a QT interval prolongation (10 patients ≥ 480 ms). There were no sudden deaths or major cardiac events during the observation period. CONCLUSIONS Our results indicate that the QT interval prolongation is not a negative prognostic marker in the addicted population, even with associated diseases. ECG should be performed when other drugs potentially prolonging QT interval are associated. Substance abuse patients should be followed by multidisciplinary teams, and blood tests and ECGs should be performed regularly.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008133 Long QT Syndrome A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME. Electrocardiogram QT Prolonged
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D002047 Buprenorphine A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. 6029-M,Buprenex,Buprenorphine Hydrochloride,Buprex,Prefin,RX-6029-M,Subutex,Temgesic,Temgésic,6029 M,6029M,Hydrochloride, Buprenorphine,RX 6029 M,RX6029M
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females

Related Publications

Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 1998, Journal of addictive diseases,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 1989, American journal of preventive medicine,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
May 2018, The Journal of clinical endocrinology and metabolism,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
December 2023, Acta cardiologica,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 2016, The Journal of nutrition,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 2003, International journal of food sciences and nutrition,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 2012, Psychosomatics,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
May 1984, The Medical journal of Australia,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
January 2020, The New England journal of medicine,
Daniela Demarie, and Giovanna Marletta, and Massimo Imazio, and Carolina Cappa, and Silvia Ferro, and Roberto Compostino, and Enrico De Vivo, and Rita Trinchero, and Emanuele Bignamini
September 2019, The New England journal of medicine,
Copied contents to your clipboard!